CMND Clearmind Medicine Inc.
$0.87▼ -7.93%
Healthcare
Other
Volume 81.3K
Avg Volume (10D) 2.05M
Key Metrics & Fundamentals
Market Cap
$1.29M
P/E Ratio
–
Div Yield
–%
52W Range
0.85 - 524.00
% vs 50 MA
-44.51%
% vs 200 MA
-91.87%
RSI-14
25.9
MACD Histogram
-0.0800
Beta (1Y vs SPY)
0.10
Free Cash Flow
-$2.71M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.39M
COGS
–
Operating Exp
$2.18M
Operating Income
-$2.18M
EBIT
-$2.18M
Pretax Income
-$904,061
Net Income
-$907,291
EPS (Diluted)
-0.57
Price & Volume History
Loading chart…
Recent News
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
GlobeNewswire · Sep 11, 2026 12:00 PM
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
GlobeNewswire · Sep 8, 2026 11:42 AM
Clearmind Medicine to Acquire Majority Stake in Charging Robotics for $2.5 Million
MT Newswires · Sep 4, 2026 5:53 PM
Clearmind Medicine Agrees to Acquire 51% Stake in Charging Robotics for $2.5 Million
InvestorsHub · Sep 4, 2026 1:55 PM
Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis
GlobeNewswire · Sep 4, 2026 11:32 AM
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
GlobeNewswire · Sep 1, 2026 11:37 AM
NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
NewMediaWire · Aug 24, 2026 12:55 PM
SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
GlobeNewswire · Aug 24, 2026 12:51 PM
Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
GlobeNewswire · Aug 24, 2026 12:03 PM
Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
GlobeNewswire · Aug 13, 2026 11:36 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CMND's money flow as a full page
Social Sentiment
No Reddit posts found for CMND.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.